This compound is a pharmaceutical intermediate featuring a chiral amino acid structure with a hydroxyphenyl group and a pyridine-derived carbonyl moiety. Its significance lies in its use as a building block for the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-alpha-Cbz-D-2-4-diaminobutanoic acid
pharmaceutical intermediate
Methyl 5-(bromomethyl)-2-fluorobenzoate
pharmaceutical intermediate
2-(3-Hydroxy-1-adamantyl)-2-oxoacetic acid
pharmaceutical intermediate
3-Hydroxy-1-adamantyl-D-glycine
pharmaceutical intermediate
Methyl 5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate
research compound
Methyl 1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-5-((2,4,6-trifluorobenzyl)carbamoyl)-1,4-dihydropyridine-2-carboxylate
pharmaceutical intermediate
(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetic acid
UNZMURWBBRKTNN-CYBMUJFWSA-N
CC1=CC(=O)C(=CN1)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)O
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.